Interestingly, in K562, treatments of all three CGs did not activate the cleavage of Caspase-3 and 8 but resulted in cleaved PARP expression, suggesting that CGs may target different signaling components in AML and CML cells resulting in PARP cleavagee. The gene discussed is CASP3; the disease is acute myeloid leukemia.